Calliditas Therapeutics AB (CALT) Financials

CALT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 ? ?
2023-09-30 147.6 million 115.3 million
2023-06-30 157.5 million 111.0 million
2023-03-31 188.4 million 114.5 million

CALT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 ? ?
2023-09-30 -5.7 million ?
2023-06-30 -15.0 million ?
2023-03-31 22.0 million 3.5 million

CALT Net Income

No data available :(

CALT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - -
2023-09-30 72.1 million - 2.7 million
2023-06-30 79.8 million - 1.9 million
2023-03-31 120.5 million - -

CALT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 2.7 million
2023-09-30 2.5 million
2023-06-30 2.5 million
2023-03-31 2.6 million

CALT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - - - -
2023-09-30 - 16.5 million 8.1 million 15.6 million
2023-06-30 - 8.2 million 7.1 million 17.6 million
2023-03-31 242384 9.9 million 7.8 million 18.5 million

CALT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 27.0 million 1.4 million
2023-06-30 24.8 million 1.3 million
2023-03-31 41.4 million 760251

CALT

Price: $20

52 week price:
15.25
29.30

Earnings Per Share: -1.64 USD

P/E Ratio: -13.18

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 12700

Market Capitalization: 613.2 million

Links: